FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18253011000001104: Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62561401000001112 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62561501000001111 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP Betamethasone+salicylic acid 0.05/3% scalp application false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has specific active ingredient Salicylic acid true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application false Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Diprosalic scalp application (Necessity Supplies Ltd) 60 ml Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Inferred relationship Existential restriction modifier
Diprosalic 0.05%/2% scalp application (Waymade Healthcare Plc) 60 ml Is a True Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start